Proteome Sciences (PRM)

Company name:Proteome Sciences Plc
EPIC:PRMTrading Currency:GBX
Market Sector:ASM7ISIN:GB0003104196
Market Segment:AMSMShare Type:DE
WWW Address: 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 5.65 -0.2 [-3.42] 5.65 5.95 5.70 5.70 5.65 178,365
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 16.65 294.65 -0.00 0.05 - 113.00 - 9.95 - 3.02

Proteome Sciences Key Figures

(at previous day's close)
Market Cap.16.65m
Shares In Issue294.65m
Prev. Close5.85
PE Ratio113.00 
Dividend Yield-%
EPS - basic0.05p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.01p
Return On Equity (ROE)-%
Operating Margin-0.77%
PEG Factor1.01 
EPS Growth Rate111.36%
Dividends PS Growth Rate-%
Net Debt11.21m
Gross Gearing143.68%
Quick Assets1.29m
Net Working Capital-9.45m
Intangibles / Fixed Assets77.34%
Turnover PS1.58p
Pre-Tax Profit PS-0.01p
Retained Profit PS0.05p
Cash PS0.27p
Net Cash PS-3.67p
Net Tangible Asset Value PS *-2.87p
Net Asset Value PS-1.24p
Spread0.30 (5.04%) 

Proteome Sciences Balance Sheet


Share Price Performance

Sample Period HighLow
1 week5.855.55
4 weeks7.155.50
12 weeks8.655.50
1 year9.953.02

Share Price Chart (5 years)

Proteome Sciences Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week5.70-0.05-0.885.550.235.81
4 weeks6.80-1.15-16.915.500.405.78
12 weeks8.55-2.90-33.925.500.366.89
26 weeks3.901.7544.873.520.735.64
1 year4.501.1525.563.020.525.12
3 years3.352.3068.662.220.434.32
5 years17.25-11.60-

Proteome Sciences Key Management Ratios

Proteome Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio6,083.70 
PE Ratio113.00 
Tobin's Q Ratio 2.16 
Tobin's Q Ratio (excl. intangibles)5.23 
Dividend Yield-%
Market-to-Book Ratio-4.56 
Price-to-Pre-Tax Profit PS-462.43 
Price-to-Retained Profit PS111.73 
Price-to-Cash Flow PS832.38 
Price-to-Sales PS3.58 
Price-to-Net Tangible Asset Value PS-1.97 
Price-to-Cash PS20.84 
Net Working Capital PS-3.21 
Price Pct to Working Capital PS-1.76%
Earnings Yield0.88%
Average PE59.00 
Years in average1 
PE to PE average191.53%

Proteome Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio-12.40%
Debt-to-Equity Ratio-0.11 
Debt-to-Equity Ratio (excl. Intgbl)-0.05 
Debt-to-Equity Market Value0.02 
Net Gearing134.12%
Net Gearing (excl. Intangibles)314.82%
Gross Gearing143.68%
Gross Gearing (excl. Intangibles)337.25%
Gearing Under 1 Year138.86%
Gearing Under 1 Year (excl. Intgbl)325.94%
(Liquidity Ratios)
Net Working Capital to Total Assets-113.07%
Current Ratio0.19 
Quick Ratio (Acid Test)0.11 
Liquidity Ratio0.07 
Cash & Equiv/Current Assets37.06%
(Solvency Ratios)
Enterprise Value16.25m
CFO/Attributable Profit0.13 
Total Debt/Equity Market Value0.72 
Total Debt/Sales2.58 
Total Debt/Pre-Tax Profit-333.69 
Total Debt12.01m
Total Debt/Net Current Assets-1.27%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)

Proteome Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)1.94%
Net Profit Margin3.20%
Assets Turnover0.61 
Return On Equity (ROE)-%
Return On Investment (ROI)-4.43%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues3.20%
(Asset Utilisation Multiples)
Shareholders Equity Turnover-1.25 
Fixed Assets Turnover0.89 
Current Assets Turnover1.90 
Net Working Capital Turnover 
Inventory Turnover4.61 
(Other Operating Ratios)
Total Assets-to-Sales1.65 
Debt Collection Period44.45Days

Proteome Sciences Dividends

Sorry No Data Available

Proteome Sciences Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-2.94-106.09%-2.05-60.74%-1.66-48.67%-0.04-0.77%m
attributable profit-2.28-82.19%-2.50-73.88%-1.31-38.52%0.153.20%m
retained profit-2.28-82.19%-2.50-73.88%-1.31-38.52%0.153.20%m
eps - basic (p)-0.96 -0.85 -0.44 0.05 
eps - diluted (p)-0.96 -0.85 -0.44 0.05 
dividends per share- - - - 

Proteome Sciences Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets0.596.10%0.283.76%0.060.80%0.080.90%m
intangibles intangibles4.2243.48%4.2256.41%4.2260.03%4.8057.40%m
fixed investments fixed investments--%--%--%1.3315.92%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.606.19%0.9512.65%1.1516.32%0.8710.42%m
debtors debtors1.4114.49%1.1215.03%0.659.22%0.495.81%m
cash & securities cash & securities2.8829.73%0.9112.14%0.9613.63%0.809.56%m
creditors - short creditors - short9.3696.52%9.67129.36%10.50149.45%11.61138.86%m
creditors - long creditors - long0.535.43%0.364.85%0.344.88%0.404.82%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves-0.19-1.95%-2.56-34.21%-3.82-54.33%-3.65-43.68%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Proteome Sciences Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-1.99-1.70-0.500.02m
Pre-Financing CF-2.03-1.72-0.51-0.04m
Retained CF0.88-1.920.03-0.10m

Proteome Sciences Brokers

Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 12:50:06